EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC0

Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study

Nkiru Nwokoye, Austin Ihesie, Jamiu Olabamiji, Kingsley Ochei, Rupert Eneogu, Michael Umoren, Femi Odola, Debby Nongo, Aderonke Agbaje, Bethrand Odume, Omosalewa Oyelaran, Wayne van Germert und 5 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0316204 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Nkiru Nwokoye und 16 weiteren Autor:innen. Beteiligte Einrichtung: KNCV Nigeria, Abuja, Nigeria. Hauptthemen laut MEDLINE: Health Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: USAID through STOP TB Partnership.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

World Health Organization in the year 2020 recommended the use of Truenat as a replacement for smear microscopy in Tuberculosis (TB) diagnosis and detection of rifampicin resistance. This study was designed to assess enablers and barriers to effective implementation of Truenat assays for TB diagnosis in Nigeria and determine the acceptability of use of Truenat among healthcare workers and TB Program managers in Nigeria.

Methods

A descriptive exploratory study design was used. Qualitative data were collected via Zoom platform using a pre-tested focus group discussion (FGD) guide and key informant interview (KII) guide. Four FGDs were conducted among Truenat laboratory staff, State Quality Assurance Officers, Local Government Tuberculosis Supervisors and Clinicians working at Truenat sites. Three KIIs were conducted among laboratory leads of Truenat implementing partners and the National TB Control Program.

Results

All the participants attested to the reliability and acceptability of Truenat results, they also highlighted the portability and ease-of-use especially for community outreach testing. Stakeholder engagement, training of Truenat laboratory staff and the perceived low operational cost associated with Truenat were the enablers of Truenat implementation. Major barriers to the implementation included human resource for health constraints, lack of power supply, frequent Trueprep breakdown and Truenat machine connectivity. The same human resource constraint was viewed as the major barrier to scale up of Truenat while employment and retention of Truenat staff coupled with training were seen as the facilitators to scale-up. The participants implored the manufacturers of Truenat to increase the number of modules for Truenat, enable the use of stool for diagnosis of TB and attach a solar panel to the machine.

Conclusion

Truenat has gained high acceptance among health workers and TB Program managers in Nigeria. The perceived low operational cost and low infrastructural requirements have been a major boost. There is a need to ensure the retention of health workers especially the Truenat laboratory staff. Training should be sustained including the payment of incentives. Increasing the number of modules of the Truenat machine, enabling the use of stool for TB diagnosis and having a solar panel attached to Truenat machine are essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PersonnelHumansNigeriaFemaleTuberculosis, Multidrug-ResistantMaleQualitative ResearchTuberculosisFocus GroupsAdultMycobacterium tuberculosisRifampin

Substanzen

Rifampin

Autor:innen und Institutionen

  • KNCV Nigeria, Abuja, Nigeria.
  • HIV AIDS & TB Office, USAID Nigeria, Abuja, Nigeria.
  • IHV-Nigeria, Lagos, Nigeria.
  • USAID Leap Project, Abuja, Nigeria.
  • STOP TB Partnership, Geneva, Switzerland.
  • Federal Ministry of Health, Abuja, Nigeria.

ORCID-Profile: Edmund Ndudi Ossai

Förderung

  • USAID through STOP TB Partnership

Zitieren

APA

Nwokoye, N., Ihesie, A., Olabamiji, J., Ochei, K., Eneogu, R., Umoren, M., Odola, F., Nongo, D., Agbaje, A., Odume, B., Oyelaran, O., van Germert, W., Mupfumi, L., Emeka, E., Anyaike, C., Scalise, S. C., & Ossai, E. N. (2024). Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study. PLOS ONE. https://doi.org/10.1371/journal.pone.0316204

Vancouver

Nwokoye N, Ihesie A, Olabamiji J, Ochei K, Eneogu R, Umoren M, et al. Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study. PLOS ONE. 2024. doi:10.1371/journal.pone.0316204

BibTeX
@article{Nwokoye2024,
  author = {Nwokoye, Nkiru and Ihesie, Austin and Olabamiji, Jamiu and Ochei, Kingsley and Eneogu, Rupert and Umoren, Michael and Odola, Femi and Nongo, Debby and Agbaje, Aderonke and Odume, Bethrand and Oyelaran, Omosalewa and van Germert, Wayne and Mupfumi, Lucy and Emeka, Elom and Anyaike, Chukwuma and Scalise, Sarah Cook and Ossai, Edmund Ndudi},
  title = {Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0316204}
}
Kostenlos starten →